share_log

Biogen | 8-K: Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024

Biogen | 8-K: Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024

渤健公司 | 8-K:Biogen公布了2023年第四季度和全年业绩,并预计将在2024年恢复非公认会计准则每股收益增长
SEC announcement ·  02/13 07:09
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息